Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
doi: 10.1101/cshperspect.a028613 87 SiegalFPKadowakiNShodellMFitzgerald-BocarslyPAShahKHoSet al
#### Receptor-binding comparison table Section summary
When it advanced to larger Phase III trials and an additional dose-ranging study, it didnt work and thus was not granted the indication (Richards C et al, J Psychopharmacol 2017;31(9):11901203
Prof Paul Morgan : No conflicts Prof Tara Spires-Jones: I have no conflicts with this study but have received payments for consulting, scientific talks, or collaborative research over the past 10 years from AbbVie, Sanofi, Merck, Scottish Brain Sciences, Jay Therapeutics, Cognition Therapeutics, Ono, and Eisai, and direct a company Spires-Jones Neuroscience, Ltd to act as a consultant
US$ 22.58
US$ 24.51
US$ 26.31
US$ 26.37
US$ 25.45
